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Available online 16 September 2014Ultrasonography is a noninvasive and radiation-free imaging
modality. In an area with a high prevalence of viral hepatitis
and hepatocellular carcinoma, such as Taiwan, ultrasonog-
raphy is an inexpensive and useful technique for screening of
liver tumor. Of note, ultrasonography yields higher imaging
resolution of the liver parenchyma and tumors compared to
computed tomography (CT); however, the technology has
limitations. Specifically, ultrasonography has a higher false-
positive rate and less specific tumor localization.
Here, we report a case in which an enlarging liver tumor
was detected during ultrasonography, but missed by CT and
angiography.
A woman born in 1944 was shown to be a hepatitis B virus
(HBV) carrier during a health examination in 2002. She has
been followed regularly at a local hospital since then. In
August 2008, an ultrasonographic examination identified an
ill-defined nodule. However, subsequent CT in September
2008 revealed negative findings (Fig. 1 middle panel CT
200809). The patient scheduled a confirmation evaluation
at our hospital in December 2008. Our ultrasonographic
imaging showed liver cirrhosis and an ill-defined nodule in
segment 5 (Fig. 1, upper panel US 200812); alanine trans-
aminase level was 1e2 times the normal value; HBV DNA
was 38.3 million copies (mcps)/mL; and a-fetoprotein levelConflicts of interest: All authors declare no conflicts of interest.
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underwent close-scheduled follow-up evaluations.
In July 2009, a 2.5-cm mass was noted in liver segment 5
by ultrasonographic examination (Fig. 1, upper panel US
200909). The a fetoprotein level was 26 ng/mL. The sub-
sequent cytologic diagnosis was Grade II hepatocellular
carcinoma. Hepatic artery angiography was performed
(Fig. 1, lower panel angio 20091023). However, angiography
at that time failed to reveal any remarkable hypervascular
tumors. Subsequent lipiodol CT also did not demonstrate
the tumor (Fig. 1, lower panel CT 20091102).
The mass continued to enlarge based on serial ultrasono-
graphic examinations. The HBV DNA level was 32.76 mcps/
mL. When the National Health Insurance began to cover
antiviral therapy for patients with liver cirrhosis, we initiated
entecavir (0.5 mg/day) in December 2010. Although the mass
was demonstrated during ultrasonographic examinations,
angiography failed to reveal a remarkable hypervascular
tumor (Fig. 1, lower panel angio 20110216). Nevertheless, the
tumor continued to enlarge to 3.5 cm under serial ultraso-
nographic examinations (Fig. 1, upper panel US 201105),
while CT showed an ill-defined lesion in segment 5 on Oct.
2009 (Fig. 1, middle panel CT 200910) and did not show a
definite lesion on May 2011 (Fig. 1, middle panel CT 201105).
With patient consent, a biopsy was performed and confirmed
Grade I hepatocellular carcinoma. Immunohistochemistry
showed glypican-3 positivity. In considering hypovascularity
of the tumor, radiofrequency ablation rather than hepatic
arterial embolization was performed in May 2011. The tumor
was shrunk to 2 cm and maintained at the same size up to
January 2014.of Ultrasound in Medicine. Open access under CC BY-NC-ND license.
Fig. 1 Upper panels: Sequential ultrasonography revealed an ill-defined nodule in segment 5 in December 2008 (left); a 2.5 cm
nodule in September 2009 (middle); a 3.5 cm mass in May 2011(right). Middle panels: Sequential CT scan did not identify liver tumor
in September 2008 (left) and May 2011 (right). An ill-defined nodule was suspected in October 2009 (middle). Lower panels:
Angiography on October 23, 2009 (left) and February 16, 2011 (right) did not identify any tumor. A lipiodol CT scan did not showed
any mass on November 2, 2009 (middle).
130 D.-I. TaiWhen ultrasonographic examinations demonstrate a
progressively enlarging tumor that cannot be confirmed by
CT or angiography, a histological examination should be
performed for diagnostic purposes, accompanied by surgi-
cal excision or local ablation. In such cases, hepatic artery
embolization is not an appropriate treatment.
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